Human papillomavirus vaccination coverage and knowledge, perceptions and influencing factors among university students in Guangzhou, China

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• WHO. Cervical cancer. 2018 [accessed 2018 Apr 25]. http://www.who.int/cancer/prevention/diagnosis-screening/cervical-cancer/en/ .
   Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. doi:10.1002/ijc.29210.
   PubMed Web of Science ®Google Scholar
• Denny L. Nine-valent human papillomavirus vaccine: great science, but will it save lives? Lancet. 2017;390(10108):2123–24. doi:10.1016/S0140-6736(17)32144-X.
   PubMed Web of Science ®Google Scholar
• Bruni L, Diaz M, Barrionuevo-Rosas L, Herrero R, Bray F, Bosch FX, De Sanjosé S, Castellsagué X. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health. 2016;4(7):e453–63. doi:10.1016/S2214-109X(16)30099-7.
   PubMed Web of Science ®Google Scholar
• WHO. Countries with HPV vaccine in the national immunization programme; and planned introductions in 2018. 2018 [accessed 2018 Oct 4]. https://www.who.int/immunization/monitoring_surveillance/data/en/ .
   Google Scholar
• Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet. 2011;377(9783):2085–92. doi:10.1016/S0140-6736(11)60551-5.
   PubMed Web of Science ®Google Scholar
• (CDC) CfDCaP. HPV vaccination coverage data. 2018 [accessed 2018 Aug 23]. https://www.cdc.gov/hpv/hcp/vacc-coverage/.
   Google Scholar
• Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet. 2013;382(9895):889–99. doi:10.1016/S0140-6736(13)60022-7.
   PubMed Web of Science ®Google Scholar
• Huh WK, Joura EA, Giuliano AR, Iversen O-E, De Andrade RP, Ault KA, Bartholomew D, Cestero RM, Fedrizzi EN, Hirschberg AL, et al. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial. Lancet. 2017;390(10108):2143–59. doi:10.1016/S0140-6736(17)31821-4.
   PubMed Web of Science ®Google Scholar
• McGregor S, Saulo D, Brotherton JML, Liu B, Phillips S, Skinner SR, Luey M, Oliver L, Stewart M, Tabrizi SN, et al. Decline in prevalence of human papillomavirus infection following vaccination among Australian indigenous women, a population at higher risk of cervical cancer: the VIP-I study. Vaccine. 2018;36(29):4311–16. doi:10.1016/j.vaccine.2018.05.104.
   PubMed Web of Science ®Google Scholar
• Drolet M, Benard E, Boily MC, Ali H, Baandrup L, Bauer H, Beddows S, Brisson J, Brotherton JML, Cummings T, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2015;15(5):565–80. doi:10.1016/S1473-3099(14)71073-4.
   PubMed Web of Science ®Google Scholar
• Spinner C, Ding L, Bernstein DI, Brown DR, Franco EL, Covert C, Kahn JA. Human papillomavirus vaccine effectiveness and herd protection in young women. Pediatrics. 2019;143(2):e20181902. doi:10.1542/peds.2018-1902.
   PubMed Web of Science ®Google Scholar
• Denny L. Control of cancer of the cervix in low- and middle-income countries. Ann Surg Oncol. 2015;22(3):728–33. doi:10.1245/s10434-014-4344-8.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32. doi:10.3322/caac.21338.
   PubMed Web of Science ®Google Scholar
• Li K, Li Q, Song L, Wang D, Yin R. The distribution and prevalence of human papillomavirus in women in mainland China. Cancer. 2019; 125(7):1030–1037. doi: 10.1002/cncr.32003.
   Web of Science ®Google Scholar
• Choi HC, Leung GM, Woo PP, Jit M, Wu JT. Acceptability and uptake of female adolescent HPV vaccination in Hong Kong: a survey of mothers and adolescents. Vaccine. 2013;32(1):78–84. doi:10.1016/j.vaccine.2013.10.068.
   PubMed Web of Science ®Google Scholar
• Li SL, Lau YL, Lam TH, Yip PS, Fan SY, Ip P. HPV vaccination in Hong Kong: uptake and reasons for non-vaccination amongst Chinese adolescent girls. Vaccine. 2013;31(49):5785–88. doi:10.1016/j.vaccine.2013.10.027.
   PubMed Web of Science ®Google Scholar
• Yin Y. HPV vaccination in China needs to be more cost-effective. Lancet. 2017;390(10104):1735–36. doi:10.1016/S0140-6736(17)32606-5.
   PubMed Web of Science ®Google Scholar
• Canfell K, Shi JF, Lew JB, Walker R, Zhao F-H, Simonella L, Chen J-F, Legood R, Smith MA, Nickson C, et al. Prevention of cervical cancer in rural China: evaluation of HPV vaccination and primary HPV screening strategies. Vaccine. 2011;29(13):2487–94. doi:10.1016/j.vaccine.2010.12.085.
   PubMed Web of Science ®Google Scholar
• Li J, Li LK, Ma JF, Wei L-H, Niyazi M, Li C-Q, Xu A-D, Wang J-B, Liang H, Belinson J, et al. Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China. Vaccine. 2009;27(8):1210–15. doi:10.1016/j.vaccine.2008.12.020.
   PubMed Web of Science ®Google Scholar
• Lasset C, Kalecinski J, Regnier V, Barone G, Leocmach Y, Vanhems P, Chauvin F, Lutringer-Magnin D. Practices and opinions regarding HPV vaccination among French general practitioners: evaluation through two cross-sectional studies in 2007 and 2010. Int J Public Health. 2014;59(3):519–28. doi:10.1007/s00038-014-0555-9.
   PubMed Web of Science ®Google Scholar
• Brabin L, Roberts SA, Stretch R, Baxter D, Chambers G, Kitchener H, McCann R. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ. 2008;336(7652):1056–58. doi:10.1136/bmj.39541.534109.BE.
   PubMed Web of Science ®Google Scholar
• Forster AS, Marlow LA, Wardle J, Stephenson J, Waller J. Understanding adolescents’ intentions to have the HPV vaccine. Vaccine. 2010;28(7):1673–76. doi:10.1016/j.vaccine.2009.11.082.
   PubMed Web of Science ®Google Scholar
• Forster AS, Waller J, Bowyer HL, Marlow LA. Girls’ explanations for being unvaccinated or under vaccinated against human papillomavirus: a content analysis of survey responses. BMC Public Health. 2015;15:1278. doi:10.1186/s12889-015-2657-6.
   PubMed Web of Science ®Google Scholar
• Gefenaite G, Smit M, Nijman HW, Tami A, Drijfhout IH, Pascal A, Postma MJ, Wolters BA, Van Delden JJM, Wilschut JC, et al. Comparatively low attendance during human papillomavirus catch-up vaccination among teenage girls in the Netherlands: insights from a behavioral survey among parents. BMC Public Health. 2012;12(1):498. doi:10.1186/1471-2458-12-498.
   PubMed Web of Science ®Google Scholar
• Giambi C, D’Ancona F, Del Manso M, De Mei B, Giovannelli I, Cattaneo C, Possenti V, Declich S. Exploring reasons for non-vaccination against human papillomavirus in Italy. BMC Infect Dis. 2014;14(1):545. doi:10.1186/s12879-014-0545-9.
   PubMed Web of Science ®Google Scholar
• Hofman R, van Empelen P, Richardus JH, De Kok IMCM, De Koning HJ, Van Ballegooijen M, Korfage IJ. Predictors of HPV vaccination uptake: a longitudinal study among parents. Health Educ Res. 2014;29(1):83–96. doi:10.1093/her/cyt092.
   PubMed Web of Science ®Google Scholar
• Lee Mortensen G, Adam M, Idtaleb L. Parental attitudes towards male human papillomavirus vaccination: a pan-European cross-sectional survey. BMC Public Health. 2015;15:624. doi:10.1186/s12889-015-1863-6.
   PubMed Web of Science ®Google Scholar
• Maier C, Maier T, Neagu CE, Vladareanu R. Romanian adolescents’ knowledge and attitudes towards human papillomavirus infection and prophylactic vaccination. Eur J Obstet Gynecol Reprod Biol. 2015;195:77–82. doi:10.1016/j.ejogrb.2015.09.029.
   PubMed Web of Science ®Google Scholar
• Mammas IN, Theodoridou M, Koutsaftiki C, Bertsias G, Sourvinos G, Spandidos DA. Vaccination against human papillomavirus in relation to financial crisis: the “evaluation and education of Greek female adolescents on human papillomaviruses’ prevention strategies” ELEFTHERIA study. J Pediatr Adolesc Gynecol. 2016;29(4):362–66. doi:10.1016/j.jpag.2015.12.007.
   PubMed Web of Science ®Google Scholar
• Remschmidt C, Walter D, Schmich P, Wetzstein M, Delere Y, Wichmann O. Knowledge, attitude, and uptake related to human papillomavirus vaccination among young women in Germany recruited via a social media site. Hum Vaccines Immunother. 2014;10(9):2527–35. doi:10.4161/21645515.2014.970920.
   PubMed Web of Science ®Google Scholar
• Byrd TL, Wilson KM, Smith JL, Coronado G, Vernon SW, Fernandez-Esquer ME, Thompson B, Ortiz M, Lairson D, Fernandez ME, et al. AMIGAS: a multicity, multicomponent cervical cancer prevention trial among Mexican American women. Cancer. 2013;119(7):1365–72. doi:10.1002/cncr.27926.
   PubMed Web of Science ®Google Scholar
• Staples JN, Wong MS, Rimel BJ. An educational intervention to improve human papilloma virus (HPV) and cervical cancer knowledge among African American college students. Gynecol Oncol. 2018;149(1):101–05. doi:10.1016/j.ygyno.2017.10.015.
   PubMed Web of Science ®Google Scholar
• Maxwell AE, Wang JH, Young L, Crespi CM, Mistry R, Sudan M, Bastani R. Pilot test of a peer-led small-group video intervention to promote mammography screening among Chinese American immigrants. Health Promot Pract. 2011;12(6):887–99. doi:10.1177/1524839909355550.
   PubMedGoogle Scholar
• Zhao FH, Xu LN, Hong Y, Niyazi M, Gao XH, Ju LR, Zhang LQ, Feng XX, Duan XZ, Qiao YL. A multi-center survey on age of sexual debut in Chinese women: suggestions for optimal age of HPV vaccination in China. Cancer Epidemiol. 2012; 36(4):384–90. doi:10.1016/j.canep.2012.01.009.
   Google Scholar
• Simms KT, Steinberg J, Caruana M, Smith MA, Lew J-B, Soerjomataram I, Castle PE, Bray F, Canfell K. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study. Lancet Oncol. 2019;20:394–407. doi:10.1016/S1470-2045(18)30836-2.
   PubMed Web of Science ®Google Scholar
• Yuen WWY, Lee A, Chan PKS, Tran L, Sayko E. Uptake of human papillomavirus (HPV) vaccination in Hong Kong: facilitators and barriers among adolescent girls and their parents. PLoS One. 2018;13(3):e0194159. doi:10.1371/journal.pone.0194159.
   PubMed Web of Science ®Google Scholar
• (CDC) CfDCaP. Vaccines for children program (VFC). [ accessed 2018 May 25]. https://www.cdc.gov/vaccines/programs/vfc/about/index.html .
   Google Scholar
• Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169–82. doi:10.1016/S0140-6736(18)32470-X.
   PubMed Web of Science ®Google Scholar
• Zhou HL, Zhang W, Zhang CJ, Wang S-M, Duan Y-C, Wang J-X, Yang H, Wang X-Y. Prevalence and distribution of human papillomavirus genotypes in Chinese women between 1991 and 2016: a systematic review. J Infect. 2018;76(6):522–28. doi:10.1016/j.jinf.2018.02.008.
   PubMed Web of Science ®Google Scholar